More than 60 percent of palliative care clinicians report burnout, according to a study presented at the American Society of Clinical Oncology's inaugural Palliative Care in Oncology Symposium, held from Oct. 24 to 25 in Boston.
The childhood pneumococcal conjugate vaccine may be contributing to fewer infections from antibiotic-resistant "superbugs," according to new research. The findings are being presented at the annual meeting of the Infectious Diseases Society of America (IDWeek), held from Oct. 8 to 12 in Philadelphia.
Carl Dieffenbach, MD, discusses the changes in HIV treatments in the 30 years since it started making headlines.
Even though Hispanics in the United States become infected with HIV at rates triple those of whites, less than half of Hispanics with the virus are receiving adequate treatment, according to research published in the Oct. 10 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
For treatment-naive patients infected with HIV-1, 3 nonnucleoside reverse transcriptase inhibitor-sparing initial antiretroviral regimens can attain similarly high rates of virologic control, according to a study published in the Oct. 7 issue of the Annals of Internal Medicine.
An Italian toddler thought cured of HIV with early aggressive treatment following birth has suffered a relapse, his doctors report. The 3-year-old child's viral levels of HIV rebounded 2 weeks after doctors took him off antiretroviral medications, according to a case report published in the Oct. 4 issue of The Lancet. The child's HIV levels had been undetectable since he was 6 months old due to aggressive drug therapy that doctors started within 12 hours of his birth.